Εξώφυλλο

Treatment of granulomatous perioral dermatitis with 1.5% topical ruxolitinib cream

Αποθηκεύτηκε σε:

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Sophia S. Tran, BS (Συγγραφέας), Benjamin Ungar, MD (Συγγραφέας), Patrick M. Brunner, MD, MSc (Συγγραφέας)
Μορφή:	Βιβλίο
Έκδοση:	Elsevier, 2024-05-01T00:00:00Z.
Θέματα:	article
Διαθέσιμο Online:	Connect to this object online.
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια

Granulomatous perioral dermatitis
από: Nadezhda V. Krasnova, κ.ά.
Έκδοση: (2023)

The use of topical ruxolitinib 1.5% cream in frontal fibrosing alopecia: A case report
από: Deesha Desai, BS, κ.ά.
Έκδοση: (2024)

Topical steroid withdrawal treated with ruxolitinib cream
από: Moira Shea, BS, κ.ά.
Έκδοση: (2024)

Improvement of necrobiosis lipoidica with topical ruxolitinib cream after prior nonresponse to compounded topical tofacitinib cream
από: Shannon Nugent, BS, κ.ά.
Έκδοση: (2022)

Treatment of cutaneous lupus with topical ruxolitinib cream
από: Jonathan J. Park, PhD, κ.ά.
Έκδοση: (2022)

Delayed granulomatous eruption of the nose associated with ruxolitinib
από: Margaret Brown, MD, κ.ά.
Έκδοση: (2020)

Granulomatous variant of scleromyxedema successfully treated with topical ruxolitinib, dapsone and intravenous immunoglobulin
από: Donglin Zhang, BA, κ.ά.
Έκδοση: (2023)

Ruxolitinib cream for the treatment of granuloma annulare
από: Austin J. Piontkowski, BS, κ.ά.
Έκδοση: (2024)

Ruxolitinib cream for the treatment of cutaneous sarcoidosis
από: Jeffrey S. Smith, MD, PhD, κ.ά.
Έκδοση: (2023)

Topical ruxolitinib in the treatment of refractory facial seborrheic dermatitis
από: Eleanor Pope, BA, κ.ά.
Έκδοση: (2022)

Recalcitrant Hailey-Hailey disease successfully treated with topical ruxolitinib cream and dupilumab
από: Juna Khang, BA, κ.ά.
Έκδοση: (2023)

Efficacy and Safety of Ruxolitinib Cream in Atopic Dermatitis Based on Previous Medication History
από: Andrew Blauvelt, κ.ά.
Έκδοση: (2024)

Efficacy of topical ruxolitinib for cutaneous dermatomyositis
από: Aviya Lanis, MD, κ.ά.
Έκδοση: (2024)

Letter in response to the case report "Topical ruxolitinib in the treatment of refractory facial seborrheic dermatitis"
από: Meron Teklu, MD, κ.ά.
Έκδοση: (2023)

Recalcitrant lichen planus pigmentosus treated with topical ruxolitinib
από: Hannah L. Cornman, BS, κ.ά.
Έκδοση: (2023)

Topical ruxolitinib for the treatment of granuloma faciale
από: Alan Wong, DO, κ.ά.
Έκδοση: (2023)

Satisfaction with Control of Mild to Moderate Atopic Dermatitis with Ruxolitinib Cream: US Physician and Patient Perspectives
από: Lawrence F. Eichenfield, κ.ά.
Έκδοση: (2024)

Intractable chronic granulomatous perioral dermatitis in patients receiving growth hormone therapy: A new association between CGPD and GH
από: Ji Young Young, κ.ά.
Έκδοση: (2020)

Porokeratoma treated with topical 5% 5-fluorouracil cream
από: Steve S. Li, BA, κ.ά.
Έκδοση: (2021)

A Case of Perioral Dermatitis Successfully Treated with Abrocitinib
από: Teng Y, κ.ά.
Έκδοση: (2023)

Educational Case: Granulomatous Dermatitis
από: Anne M. Stowman MD
Έκδοση: (2019)

Developing a JAK Inhibitor for Targeted Local Delivery: Ruxolitinib Cream
από: Paul Smith, κ.ά.
Έκδοση: (2021)

Localized reactive granulomatous dermatitis secondary to erythema migrans
από: Dylan J. Badin, BS, κ.ά.
Έκδοση: (2020)

Association of perioral dermatitis with facial mask usage during the COVID-19 pandemic: A retrospective study
από: William J. Nahm, BA, κ.ά.
Έκδοση: (2023)

Infiltração Cutâneo-Mucosa Perioral / Perioral mucocutaneous infiltration
από: Mariana Batista, κ.ά.
Έκδοση: (2018)

Penatalaksanaan Stomatitis Alergika Disertai Dermatitis Perioral Akibat Alergi Telur
από: Erna Sung, κ.ά.
Έκδοση: (2017)

Perioral pigmentation
από: Siddharth Bhatt, κ.ά.
Έκδοση: (2022)

Reactive granulomatous dermatitis: A useful and encompassing term
από: Karolyn Ann Wanat, MD, κ.ά.
Έκδοση: (2022)

Designing a Topical Nanoliposomal Formulation of Ruxolitinib Phosphate
από: Atefeh Naeimifar, κ.ά.
Έκδοση: (2023)

Reactive granulomatous dermatitis following COVID-19 vaccination
από: Grecia Figueroa-Ramos, MD, κ.ά.
Έκδοση: (2024)

Palisaded neutrophilic granulomatous dermatitis: Spectrum of histologic findings in a single patient
από: Jessica E. Kalen, BS, κ.ά.
Έκδοση: (2017)

Topical ruxolitinib 1.5% (JAK1/JAK2 inhibitor) improves clinical and patient‐reported outcomes in moderate to severe chronic hand dermatitis: Data from a small open‐label trial
από: Hannah D. Smith, κ.ά.
Έκδοση: (2024)

Resolution of microneedling-associated granulomatous dermatitis with oral methotrexate
από: Elise D. Martin, MD, κ.ά.
Έκδοση: (2021)

A case of interstitial granulomatous dermatitis presenting in a patient with necrotizing sarcoid granulomatosis
από: Rachel Elsanadi, BS, κ.ά.
Έκδοση: (2023)

A Randomised Pilot Study on the Efficacy of Milking Cream and a Homeopathic Complex Topical Cream on Diaper Dermatitis
από: Janice Pellow, κ.ά.
Έκδοση: (2013)

Ruxolitinib Cream in Adolescents/Adults with Atopic Dermatitis Meeting Severity Thresholds for Systemic Therapy: Exploratory Analysis of Pooled Results from Two Phase 3 Studies
από: Eric L. Simpson, κ.ά.
Έκδοση: (2024)

Use of TYK2 inhibitor to relieve reactive granulomatous dermatitis due to myelodysplastic syndrome
από: Christina Huang, BS, κ.ά.
Έκδοση: (2023)

Development of sebaceous carcinoma in a patient on ruxolitinib therapy
από: Noreen Mohsin, BS, κ.ά.
Έκδοση: (2022)

Abuse of topical steroid as cosmetic cream: A social background of steroid dermatitis
από: Rathi Sanjay
Έκδοση: (2006)

Tattoo pruritus successfully treated with ruxolitinib: A case series
από: Julianna Shin, BS, κ.ά.
Έκδοση: (2024)